Life sciences

San Diego skyline
#AI / data analytics / healthtech / informatics #Data automation #Drug discovery #Events #Life sciences #SLAS2023

SLAS2023 is ready for you

Ahead of SLAS2023 in San Diego, Jill Hronek, SLAS Director, Marketing & Communications, shares her enthusiasm for the opportunities, products, technologies and innovation that this event brings together. Data is the glue that keeps automation tools working together. We’re accelerating into another year of innovation and automation at SLAS: our… Read More

#Exclusive Content

Women in Life Science Denmark
#Denmark #Diversity #Gender equality #Life sciences #Novo Nordisk #Scandinavia

Danish women’s network promotes diversity in life sciences

A science-centric network for women in senior positions across industry and academia has launched in Denmark to strengthen the life sciences industry and promote talent, diversity and inclusiveness.   Women in Life Science Denmark (WiLD) has received support from the Novo Nordisk Foundation, contributing €56,000 ($60,293) over the… Read More

#News

Scandinavia
#Drug development #Drug discovery #Life sciences #Market reporting #Scandinavia #Sweden

Scandinavia: insight into opportunities for drug discovery

DDW Editor Reece Armstrong explores the Scandinavian drug discovery sector and speaks to key players about Sweden’s place in the market. Scandinavia represents one of the most exciting but perhaps underrepresented markets for the discovery and development of pharmaceuticals. Though not without its challenges, the life sciences industry in Scandinavia… Read More

#Exclusive Content #Market Reports

Businesswomen shaking hands
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Envision Pharma #Life sciences #Mergers and acquisitions #OKRA.ai

Envision Pharma Group acquires OKRA.ai

Envision Pharma Group has acquired OKRA.ai, a provider of artificial intelligence (AI) services for the pharmaceutical and life sciences industry. “We are delighted to welcome OKRA.ai into the Envision family,” said Meg Heim, CEO, Envision Pharma Group. “The combination of Envision’s leading technology, capabilities, and solutions with OKRA.ai’s artificial intelligence… Read More

#Business & Investment #News

#AI / data analytics / healthtech / informatics #Data management #Drug discovery #Life sciences #Manufacturing #PCR

The latest drug discovery product launches

Find out what’s new in the world of tools and services for the drug discovery industry with our update below.  CFX Opus Deepwell Dx Real-Time PCR System – Bio-Rad Laboratories  Bio-Rad Laboratories has launched the CFX Opus Deepwell Dx Real-Time PCR System, which offers accurate and precise quantification… Read More

#Editor's Choice #News

#Drug development #Drug discovery #Life sciences #Lithuania #Start-ups

What Lithuania offers life sciences start-ups

Listen to this article on the DDW Podcast: DDW Editor Reece Armstrong takes a look at Lithuania’s life sciences sector and what it means for start-ups operating in the country. A one to watch, would be my first thoughts when thinking about Lithuania and its start-up sector. After a visit to the… Read More

#Exclusive Content #Start-up Zone

#Carbon emissions #Climate change #Comment #Life sciences #Pharma

Pharma’s important climate

Listen to this article on the DDW podcast: By DDW Editor Reece Armstrong The looming threat of global warming, consequences of which can already be seen and felt across the planet, will impact us all. It seems that despite a constant barrage of warnings by scientists and experts, alongside visible effects… Read More

#Exclusive Content #Opinion

#AbbVie #ABPI #Clinical trials #Eli Lilly #Life sciences #Pharmaceutical industry #Pharmaceuticals #UK #UK government

Pharma firms pull out of UK drug pricing agreement

AbbVie and Eli Lilly have left the voluntary medicines pricing agreement in protest over what they describe as “increasingly punitive revenue clawbacks”.  The companies have left the UK’s Voluntary Scheme for Branded Medicines Pricing and Access (VPAS), a long-standing agreement between government and industry with roots going back to the… Read More

#Business & Investment #News #Trending News

#AI / data analytics / healthtech / informatics #Biomarkers #Data management #Drug discovery #Life sciences #RNA sequencing

The latest drug discovery product launches

Several new products for the life sciences sector have been launched over the last month, from biomarker kits to video-based training platforms. DDW provides an update.  Breath Biopsy VOC Atlas – Owlstone Medical  The Breath Biopsy VOC Atlas is a catalogue of validated and quantitated… Read More

#Editor's Choice #News

Women working in laboratory
#Contract Research Organisations (CROs) #Cpl Sciences #Life sciences #Syneos Health

Record-breaking year for scientific clinical jobs in Europe

According to a report by Cpl Life Sciences and Vacancysoft, 2022 has remained consistently steady for the life sciences industry in Europe in terms of recruitment, though still below 2021 levels.  The yearly forecast shows that vacancies could reach around 13,684 by the end of 2022, a… Read More

#News

#3D cell culture #Drug discovery #Ex Vivo #Genomics #High Content Screening #Life sciences #Molecular Biology #Precision medicine

Podcast: Finding the right cancer drug with high-content screening

This is the latest episode of the free DDW podcast, “Finding the right cancer drug with high-content screening”. It covers an article by the same name written for Volume 23, Issue 1 – Winter 2021/22 of DDW. In the article, Lassi Paavolainen, Principal Investigator at the Institute for Molecular… Read More

#News

International Day of Action for Women's Health
#Diversity #Drug discovery #Life sciences #Women in Discovery #Women in STEM

Comment: Women in Discovery round-table welcomes men 

In the Summer 2022 issue of DDW, Jessica Woodgate and Molly Edwards from life sciences recruitment company SciPro shared with DDW their ambition to champion female leaders across drug discovery through the founding of the Women in Discovery round table. Since then, the women-only environment has flourished but in the… Read More

#Exclusive Content #Opinion

Cell culture media
#Biologics #Bioproduction #Cell and gene therapy #Cell therapy #Life sciences #Manufacturing

Fujifilm expands cell culture media manufacturing

Fujifilm Corporation has announced a $188 million investment to establish a cell culture media manufacturing facility in Research Triangle Park (RTP), North Carolina, USA.  The new site will be operated by Fujifilm Irvine Scientific, a manufacturer of cell culture solutions for life science research, bioproduction, cell therapy… Read More

#News

#AI / data analytics / healthtech / informatics #Life sciences #Pistoia Alliance #R&D #Real world data #Technology

Social media project will drive patient centricity in drug development  

The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has launched a new Community of Experts (CoE) with the aim of harnessing real-world data (RWD) from social media. The organisation is calling on technology companies, data scientists and RWD experts to join… Read More

#News

Discovery Park, Kent
#Life sciences #Neuroscience #Pfizer #Science and innovation park

UK Discovery Park plans centre of excellence for neuroscience

One the UK’s largest science and innovation parks has revealed plans to double in size as it celebrates its ten-year anniversary. Discovery Park, based near Sandwich in Kent, marked the milestone by announcing its plans for the next ten years, which include the creation of a national centre of excellence… Read More

#News